GS Labs has reached a $4.87 million settlement in response to allegations from 18 states that the company overcharged customers for COVID-19 testing and engaged in unfair business practices. Court records indicate that this settlement will allow eligible customers to receive cash back. The lawsuit highlighted concerns regarding the pricing and marketing strategies employed by GS Labs during the pandemic. Further details on the claims process for affected customers are expected to be released in the coming weeks.
Related Articles
Don't miss out on breaking stories and in-depth articles.